Health Care

A focused overview of the health care companies included in the ETF’s index, highlighting pharmaceutical, medical technology, and health services businesses that reflect Iceland’s innovation-driven health sector and its role in the broader economy.

Aker BioMarine

Aker BioMarine is a global biotechnology company specializing in the harvesting and processing of sustainably sourced Antarctic krill. The company produces krill oil and marine ingredients used across human health, nutrition, and wellness markets worldwide. Headquartered in Norway, Aker BioMarine operates a vertically integrated model that spans harvesting, processing, and ingredient development. Its products are supported by scientific research and traceability standards focused on sustainability. Aker BioMarine plays a key role in the marine-based health and nutrition sector.

Learn More

Alvotech

Alvotech is a global biopharmaceutical company focused on the development and manufacture of biosimilar medicines. The company aims to improve access to affordable biologic therapies by replicating complex reference drugs at lower cost. Listed under the ticker ALVO, Alvotech operates advanced research, development, and manufacturing facilities to support its global pipeline. Its portfolio targets treatments across autoimmune, oncology, and ophthalmology indications. Alvotech represents a growing participant in the global biosimilars market.

Learn More

Embla Medical

Embla Medical is a global medical technology company specializing in advanced prosthetics, orthotics, and bracing solutions. Through its portfolio of operating companies, including Össur and other mobility-focused brands, Embla Medical serves patients across a wide range of activity levels and clinical needs. The company is listed on the Nasdaq Copenhagen Stock Exchange and operates globally. Its products emphasize innovation, biomechanics, and patient outcomes. Embla Medical is a key player in the global mobility solutions market.

Learn More

Oculis

Oculis Holding AG is a clinical-stage biopharmaceutical company focused on developing innovative therapies for diseases of the eye. The company’s pipeline targets conditions such as diabetic macular edema, dry eye disease, and neuro-ophthalmic disorders. Oculis leverages proprietary drug delivery technologies to improve efficacy and patient outcomes. Its research and development efforts are supported by international clinical programs. Oculis represents an emerging contributor to ophthalmology-focused biotechnology.

Learn More